embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes
03 sept. 2024 06h30 HE
|
Embecta Corp.
embecta has received 510(k) clearance from the FDA for its proprietary disposable insulin delivery system, a patch pump with a 300-unit insulin reservoir.
embecta to Participate in Investor Events
22 août 2024 17h00 HE
|
Embecta Corp.
PARSIPPANY, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that...
Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results
09 août 2024 06h30 HE
|
Embecta Corp.
PARSIPPANY, N.J., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and nine...
embecta Announces Quarterly Cash Dividend
09 août 2024 06h00 HE
|
Embecta Corp.
PARSIPPANY, N.J., Aug. 09, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding...
embecta to Report Fiscal Third Quarter 2024 Financial Results
18 juil. 2024 17h00 HE
|
Embecta Corp.
PARSIPPANY, N.J., July 18, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call...
embecta-sponsored Abstracts Presented at American Diabetes Association’s 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir
24 juin 2024 06h30 HE
|
Embecta Corp.
embecta-sponsored abstracts presented at ADA's 84th Scientific Sessions highlight unmet need for patch pumps with 300u insulin reservoir
Embecta Corp. Reports Second Quarter Fiscal 2024 Financial Results
09 mai 2024 06h30 HE
|
Embecta Corp.
PARSIPPANY, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and six...
embecta Announces Quarterly Cash Dividend
09 mai 2024 06h00 HE
|
Embecta Corp.
PARSIPPANY, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding...
embecta to Participate in Investor Events
01 mai 2024 17h00 HE
|
Embecta Corp.
PARSIPPANY, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that...
embecta to Report Fiscal Second Quarter 2024 Financial Results
23 avr. 2024 17h00 HE
|
Embecta Corp.
PARSIPPANY, N.J., April 23, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call...